Cytokine trajectories after cardiopulmonary bypass in children: a systematic review and meta-analysis

Authors:

Abstract
Objective(s): To synthesize and characterize cytokine responses in children undergoing cardiopulmonary bypass for repair of congenital heart disease. Methods: We systematically searched MEDLINE, Embase, and Cochrane databases for studies published from January 1, 2000, to January 1, 2022, enrolling patients younger than 18 years who underwent cardiopulmonary bypass and reported at least one circulating cytokine or inflammatory biomarker. Title/abstract screening and data extraction were performed independently and in duplicate. Risk of bias was assessed with design-appropriate tools, and certainty of evidence ratings were assigned across time points. Results: Of 4,212 records screened, seventy-one studies met inclusion criteria, representing 3,341 children. Individual studies measured a median of two biomarkers over a median of four time points. Interleukin-6, C-reactive protein, interleukin-8, and tumor necrosis factor alpha were most frequently reported. Interleukin-6 showed the clearest and most consistent temporal pattern, with a pooled peak estimate of 182.65 picograms per millilitre (95% confidence interval, 100.94–330.50) at three hours post operative and a subsequent decline by postoperative day two. Certainty ratings were moderate to high for interleukin-6 trajectories but generally low to very low for other biomarkers owing to heterogeneity, imprecision, and sparse or short-horizon sampling. Conclusions: In children after cardiopulmonary bypass, interleukin-6 provides the most reliable postoperative signal, whereas other biomarkers are inconsistently measured and rarely linked to outcomes. Standardized sampling windows, extended follow-up beyond seventy-two hours, multiplex panels, and harmonized outcome reporting are needed to enable mechanism-based trials and targeted anti-inflammatory strategies.